CID 152036

Esorubicin

Structural Information

Molecular Formula
C27H29NO10
SMILES
C[C@H]1C[C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N
InChI
InChI=1S/C27H29NO10/c1-11-6-12(28)7-18(37-11)38-16-9-27(35,17(30)10-29)8-14-20(16)26(34)22-21(24(14)32)23(31)13-4-3-5-15(36-2)19(13)25(22)33/h3-5,11-12,16,18,29,32,34-35H,6-10,28H2,1-2H3/t11-,12+,16-,18-,27-/m0/s1
InChIKey
ITSGNOIFAJAQHJ-BMFNZSJVSA-N
Compound name
(7S,9S)-7-[(2S,4R,6S)-4-amino-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

118
References

52796
Patents

527.17914 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 528.18642 220.7
[M+Na]+ 550.16836 225.2
[M-H]- 526.17186 223.9
[M+NH4]+ 545.21296 226.3
[M+K]+ 566.14230 224.9
[M+H-H2O]+ 510.17640 211.8
[M+HCOO]- 572.17734 224.0
[M+CH3COO]- 586.19299 250.6
[M+Na-2H]- 548.15381 219.0
[M]+ 527.17859 220.7
[M]- 527.17969 220.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe